SAN DIEGO--(BUSINESS WIRE)--Feb. 22, 2019--
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical
company focused on discovering, acquiring, developing and
commercializing therapeutics in the disease areas of immunology,
inflammation and oncology, today announced that Sheila Gujrathi, M.D.,
Chief Executive Officer and Co-Founder, will present at the following
upcoming investor conferences:
-
8th Annual SVB Leerink Healthcare Conference on Wednesday,
February 27 at 11:00 a.m. ET.
- Barclays Global Healthcare Conference on Wednesday, March 13 at 3:50
p.m. ET.
About Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company focused on
discovering, acquiring, developing and commercializing therapeutics in
the disease areas of immunology, inflammation and oncology. Its goal is
to be an industry leader in each of these therapeutic areas and to
enhance and extend the lives of patients suffering from such diseases.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190222005054/en/
Source: Gossamer Bio, Inc.
For Investors:
Argot Partners
Kimberly Minarovich
Tel 212.600.1902
kimberly@argotpartners.com
For
Media:
Argot Partners
David Rosen
Tel 212.600.1902
david.rosen@argotpartners.com